Targeted Therapy Based on Tumor Genomic Analyses in Metastatic Urachal Carcinoma

Clin Genitourin Cancer. 2016 Aug;14(4):e449-52. doi: 10.1016/j.clgc.2016.03.013. Epub 2016 Mar 24.

Authors

Kah Poh Loh¹, Esther Mondo², Elizabeth A Hansen³, Lynn Sievert², Chunkit Fung², Deepak M Sahasrabudhe², Elizabeth Guancial²

Affiliations

¹ Division of Hematology/Oncology, James P. Wilmot Cancer Institute, University of Rochester, Strong Memorial Hospital, Rochester, NY. Electronic address: Melissalkp@gmail.com.
² Division of Hematology/Oncology, James P. Wilmot Cancer Institute, University of Rochester, Strong Memorial Hospital, Rochester, NY.
³ Department of Pharmacy, University of Rochester, Strong Memorial Hospital, Rochester, NY.

PMID: 27102403
DOI: 10.1016/j.clgc.2016.03.013

No abstract available

Keywords: Chemotherapy; Genomic alterations; Metastases; Next generation sequencing; Urachal cancer.

Publication types

Case Reports

MeSH terms

Adult
Antineoplastic Agents / therapeutic use*
Carcinoma / drug therapy*
Carcinoma / genetics*
Female
Genomics / methods
Humans
Middle Aged
Urinary Bladder Neoplasms / drug therapy*
Urinary Bladder Neoplasms / genetics*

Substances

Antineoplastic Agents

Supplementary concepts

Urachal cancer